Low Birthweight and Preterm Infant Feeding Trial and Supportive Care Package: Implementation Research
NCT ID: NCT06390943
Last Updated: 2025-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
695 participants
INTERVENTIONAL
2024-05-08
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
OBJECTIVES:
To implement and evaluate a co-designed facility-based lactation support/management and feeding counseling + KMC + WASH package (FB-FSP+: Facility-Based Feeding Support Package Plus) for LBW or preterm infants admitted to the neonatal intensive care unit (NICU) and their families from birth to discharge.
To implement and evaluate a co-designed, scalable transition-to-home lactation support/management and feeding counseling + KMC + WASH package (TTH-FSP+: Transition to Home Feeding Support Package Plus) for LBW or preterm infants discharged home from the NICU in India and their mothers/families.
STUDY DESIGN: This multi-site, mixed-methods adaptive implementation science research study will collect quantitative and qualitative data to evaluate the training of providers, the impact of each intervention on key infant feeding, growth, and other health outcomes, the feasibility and acceptability of each intervention for mothers and providers, and the overall experience of mother-infant dyads. Investigators will apply the RE-AIM framework to unpack Reach, Effectiveness, Adoption, Implementation, and Maintenance. Findings will lead to recommendations for iteration and scale-up of the FB- and TTH-FSP+. Investigators will evaluate multiple primary and secondary quantitative outcomes to assess effectiveness.
SAMPLE SIZE: Overall, investigators will enroll 695 participants, 50% in India, 50% in Malawi \& Tanzania: up to 520 infants (463 mothers assuming 11% twin rate), 110 mothers (in-depth interviews), 30 healthcare providers, 15 study staff, and 20 community providers.
Objective 1: A sample of 80 infants and their mothers is sufficient to detect the effect sizes for each of the primary and secondary outcomes with 80% power, 0.05 alpha. Smaller improvements in key outcomes for the pre/post analysis can be detected for the implementation study (n=80 baseline vs 240 implementation) compared to the pilot study (n=80 baseline vs 80 pilot).
Objective 2: Investigators will conduct up to 40 in-depth interviews (IDIs) with providers and 20 with mothers. A sample of 60 infants and their mothers is sufficient to detect the effect sizes for each of the primary and secondary outcomes with 80% power, 0.05 alpha.
ENROLLMENT: OBJECTIVE 1 (FB-FSP+) Mother-infant dyads (quantitative): All infants born in a study facility will receive immediate maternal and newborn care per World Health Organization recommendations, including breast milk feeding/expression support within 1 hour. Inborn LBW or preterm infants admitted to the NICU will be screened for eligibility and their mothers consented.
Mothers (qualitative): Mothers will be recruited and consented before discharge from study facilities.
Research Nurses (qualitative): Research nurses providing the intervention will be consented prior to IDIs.
Healthcare providers (quantitative): Appropriate labor ward, NICU, and step-down ward providers will be identified by facility and NICU leadership/staff to implement the FB-FSP+ and consented.
Healthcare providers (qualitative): NICU providers will be recruited and consented during study implementation.
ENROLLMENT FOR OBJECTIVE 2 (TTH-FSP+, INDIA ONLY) Mothers (quantitative): Mothers exposed to Objective 1 will be recruited around the time of discharge and consented.
Community providers (quantitative): Community providers within a given cadre(s) who provide care to LBW or preterm infants within the catchment area will be recruited and consented.
Mothers (qualitative): Mothers receiving the TTH-FSP+ will be recruited and consented during study visits.
Community providers (qualitative): Community providers will be recruited and consented after beginning implementation of the TTH-FSP+.
STUDY INTERVENTION: The FB-FSP+ and the TTH-FSP+ will build on an existing Specialized Lactation Support and Newborn Nutrition for the Small and Sick Newborn Training curriculum to include support for KMC and WASH. The FSP+ will include a training guide, Standard Operating Procedures and job aids specific to each hospital's and community's needs identified through co-design workshops with key stakeholders that utilize human-centered design methods.
DATA COLLECTION FOR OBJECTIVE 1 (FB-FSP+) Data will be collected in 3 phases.
Baseline data collection will occur over 6 weeks among eligible mother-infant dyads prior to introducing the intervention. Baseline will be the comparison group for the implementation research study and the pilot study.
A 6-week pilot study conducted by research staff in each country will assess the acceptability, feasibility, and impact of the ideal delivery of the FB-FSP+. A quick final iteration of the FSP+ will occur before implementing in phase 3.
The FB-FSP+ will be implemented for 1 year using an adaptive models-based approach. Three consecutive models will be implemented for 4 months each. Investigators will collect panel data at 1.5, 5.5, and 10.5 months after the start of implementation for 1.5 months to assess effectiveness and inform model adaptations. Different mother-infant dyads will be surveyed at each time point to assess differences in the impact of implementation over time.
Prior to start, healthcare providers will be selected and trained to implement the FSP+ as part of their regular workload. They will complete a knowledge, attitudes, and practices (KAP) survey on lactation support/management, feeding, KMC, and WASH (1) prior to training, (2) immediately post-training, and (3) 6 months post-training.
Data collection with mother-infant dyads will take 1-2 hours at one time point between NICU admission and day of discharge during panel data collection. Mothers will be asked about their demographics, pregnancy history, health, and their infants' health. Study staff will take the mother's weight and height, the infants' weight, length, head circumference and mid-upper arm circumference (MUAC), and data from mothers' and infants' charts.
A subset of 60 mothers exposed to the FB-FSP+ will be interviewed by study staff, 30 of whom whose babies received care in the NICU within 1.5 months of implementation and another 30 whose babies received care within 5.5 months. Interviews will explore mothers' experiences and perceptions of the acceptability and feasibility of the FB-FSP+.
A subset of 15-30 healthcare providers across all sites will be interviewed per time point at 1.5 months and 5.5 months after implementing the FB-FSP+. Investigators aim to interview the same providers at both times to understand how implementation has affected their practices, skills and workload over time. Interviews will explore acceptability and feasibility of the FB-FSP+ and barriers and facilitators to its implementation.
DATA COLLECTION FOR OBJECTIVE 2 (TTH-FSP+, INDIA ONLY) Baseline data collection will occur before implementing the TTH-FSP+ among mothers exposed to the FB-FSP+ and discharged home. Data collection points will be on the day of discharge and at 2 and 6 weeks post-discharge.
The TTH-FSP+ will be implemented for 6 months, using an adaptive models-based approach. Three models will be consecutively implemented for 3 months each. Quantitative and qualitative analysis will begin after 2 months to inform model adaptations. Data collection points will be on the day of discharge and at 2 and 6 weeks post-discharge.
Community providers will be trained to deliver the TTH-FSP+ for dyads residing in a defined catchment area once they are discharged home. Community providers will complete a KAP survey on feeding counseling, KMC, and WASH at three timepoints: (1) just prior to training, (2) immediately post-training, and (3) 6 months post-training.
Data collection will begin on the day of discharge prior to leaving the facility, and mothers will respond to questions about their demographics, pregnancy history, health, and their infants' health. During 2 home visits, mothers will respond to questions on breastfeeding self-efficacy and health, as well as their infants' health and feeding practices. Mothers' weight and height will be measured at one study visit. The infants' weight, length, head circumference and MUAC will be measured at each study visit.
Interviews with mothers will be done at 6 weeks post-discharge during implementation of Model 1 \& 2 and will explore their experiences with the TTH-FSP+ and their perspectives on its acceptability and feasibility .
Interviews with community providers will be conducted once during implementation of each Model 1 \& 2. Investigators aim to interview the same providers at both time points. Interviews will explore community providers' experiences delivering the TTH-FSP+ and their perspectives on its acceptability and feasibility.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obj 1 Infants receiving facility-based FSP+; Obj 2 infants receiving transition-to-home FSP+
Facility-based feeding support package plus (FB-FSP+)
Package of materials to support facility-based feeding and lactation, KMC and WASH, including a training curriculum, training guide, and implementation materials, such as Standard Operating Procedures (SOPs) and job aides
Transition-to-home feeding support package plus (TTH-FSP+)
Package of materials to support transition-to-home feeding and lactation, KMC and WASH, including a training curriculum, training guide, and implementation materials, such as Standard Operating Procedures (SOPs) and job aides
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Facility-based feeding support package plus (FB-FSP+)
Package of materials to support facility-based feeding and lactation, KMC and WASH, including a training curriculum, training guide, and implementation materials, such as Standard Operating Procedures (SOPs) and job aides
Transition-to-home feeding support package plus (TTH-FSP+)
Package of materials to support transition-to-home feeding and lactation, KMC and WASH, including a training curriculum, training guide, and implementation materials, such as Standard Operating Procedures (SOPs) and job aides
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Low birthweight (≤2.5kg) or preterm (\<37 weeks) infants admitted to NICU at study facility
* In-born infants admitted to the NICU within 24 hours of birth)
* Mother and infant alive during screening
* Mother consents for herself and infant
* Women (mothers) who are age of majority: Tanzania and India: 18+; Malawi: 16-17 and married OR 18+
Healthcare providers
* Healthcare provider who was trained to deliver the facility-based FSP+
* Healthcare provider consents for him/herself
Infants
* Infants in India-Uttar Pradesh site
* Lives within catchment areas of study facility (50km)
* Mother intends to stay in the catchment areas for 3 months post-birth with infant
Community providers
* Community provider who was trained to deliver the transition-to-home FSP+.
* Community provider consents for him/herself
Exclusion Criteria
* Out-born infants referred to study facility NICU
* Congenital anomalies or acquired conditions that interfere with feeding or placement of nasogastric/ orogastric (NG/OG) tube \[e.g., cleft lip/palate, toxoplasmosis,other agents, rubella, cytomegalovirus, and herpes (TORCH), Trisomy 21, Congenital cardiac defect, neural tube defect, gastrointestinal (GI) tract anomalies, hydrocephalus, necrotizing enterocolitis\]
* Severe birth asphyxia
* Unknown date of birth and unknown gestational age
OBJECTIVE 2 (TRANSITION-TO-HOME)
Infants
* Not screened and was not exposed to objective 1 intervention (and meet all eligibility criteria)
* Lives outside the defined catchment area
* Mother does not intend to stay in the catchment areas for 3 months post-birth with infant
Community providers
-Community provider who was not trained to deliver the transition-to-home FSP+.
1 Minute
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Children's Hospital
OTHER
Community Empowerment Lab
OTHER
Emory University
OTHER
Muhimbili University of Health and Allied Sciences
OTHER
Jawaharlal Nehru Medical College
OTHER
PATH
OTHER
University of North Carolina
OTHER
Brigham and Women's Hospital
OTHER
Harvard School of Public Health (HSPH)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katherine Semrau
Deputy Director, Ariadne Labs & Director, BetterBirth Program
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katherine Semrau, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
Ariadne Labs
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ganesh Shankar Vidyarthi Memorial Medical College
Kanpur, , India
King George Medical College
Lucknow, , India
Institute of Medical Sciences, Banaras Hindu University
Varanasi, , India
Bwaila District Hospital
Lilongwe, , Malawi
Amana Regional Hospital
Dar es Salaam, , Tanzania
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yashwant Kumar, MD
Role: primary
Shalini Tripathi, MD
Role: primary
Ashok Kumar, MD
Role: primary
Msandeni Chiume, MD
Role: primary
Karim Manji, MD MMed MPH
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB23-0273
Identifier Type: -
Identifier Source: org_study_id